Extrathymic tolerance of mature T cells: clonal elimination as a consequence of immunity.

Cell migration, chimerism, and graft acceptance. Lancet (1992) 12.24

Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76

Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J Exp Med (1996) 8.54

Class I-restricted cross-presentation of exogenous self-antigens leads to deletion of autoreactive CD8(+) T cells. J Exp Med (1997) 5.72

Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med (1993) 4.99

Tolerance exists towards resident intestinal flora but is broken in active inflammatory bowel disease (IBD) Clin Exp Immunol (1995) 4.81

Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation. Immunol Today (1993) 4.29

Type I interferons keep activated T cells alive. J Exp Med (1999) 3.98

Antigen localization and migration in immunity and tolerance. N Engl J Med (1998) 3.71

Signal 3 determines tolerance versus full activation of naive CD8 T cells: dissociating proliferation and development of effector function. J Exp Med (2003) 3.21

Lamivudine treatment can restore T cell responsiveness in chronic hepatitis B. J Clin Invest (1998) 2.97

CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J Clin Invest (1996) 2.95

Glycolipid antigen induces long-term natural killer T cell anergy in mice. J Clin Invest (2005) 2.85

Cytokine-induced survival of activated T cells in vitro and in vivo. Proc Natl Acad Sci U S A (1998) 2.71

CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells. J Exp Med (1998) 2.69

Homeostatic T cell proliferation: how far can T cells be activated to self-ligands? J Exp Med (2000) 2.55

Phenotypic and functional analysis of CD8(+) T cells undergoing peripheral deletion in response to cross-presentation of self-antigen. J Exp Med (2001) 2.49

Balancing immunity and tolerance: deleting and tuning lymphocyte repertoires. Proc Natl Acad Sci U S A (1996) 2.34

Contribution of virus-specific CD8+ cytotoxic T cells to virus clearance or pathologic manifestations of influenza virus infection in a T cell receptor transgenic mouse model. J Exp Med (1998) 2.31

Mature murine B and T cells transferred to SCID mice can survive indefinitely and many maintain a virgin phenotype. J Exp Med (1991) 2.25

T cell regulation as a side effect of homeostasis and competition. J Exp Med (2003) 2.15

T cell priming versus T cell tolerance induced by synthetic peptides. J Exp Med (1995) 2.07

Transplantation tolerance from a historical perspective. Nat Rev Immunol (2001) 2.04

IL-27 is a key regulator of IL-10 and IL-17 production by human CD4+ T cells. J Immunol (2009) 2.00

Anergy and exhaustion are independent mechanisms of peripheral T cell tolerance. J Exp Med (1995) 1.86

Intravenous injection of soluble antigen induces thymic and peripheral T-cells apoptosis. Proc Natl Acad Sci U S A (1996) 1.85

Programmed cell death of T lymphocytes during acute viral infection: a mechanism for virus-induced immune deficiency. J Virol (1993) 1.85

Cross-tolerance: a pathway for inducing tolerance to peripheral tissue antigens. J Exp Med (1998) 1.83

CTLA4 mediates antigen-specific apoptosis of human T cells. Proc Natl Acad Sci U S A (1995) 1.80

Thymic and extrathymic origins of gut intraepithelial lymphocyte populations in mice. J Exp Med (1994) 1.79

Viral and bacterial infections interfere with peripheral tolerance induction and activate CD8+ T cells to cause immunopathology. J Exp Med (1998) 1.70

Clonal anergy blocks in vivo growth of mature T cells and can be reversed in the absence of antigen. J Exp Med (1993) 1.69

Extrathymic T cell deletion and allogeneic stem cell engraftment induced with costimulatory blockade is followed by central T cell tolerance. J Exp Med (1998) 1.65

Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood. J Exp Med (1992) 1.65

Memory B cells are biased towards terminal differentiation: a strategy that may prevent repertoire freezing. J Exp Med (1997) 1.59

A two-step, two-signal model for the primary activation of precursor helper T cells. Proc Natl Acad Sci U S A (1999) 1.58

Selective apoptosis of CD4+CD8+ thymocytes by the anti-Fas antibody. J Exp Med (1995) 1.57

Viral superantigen drives extrafollicular and follicular B cell differentiation leading to virus-specific antibody production. J Exp Med (1997) 1.57

Distinct modes of macrophage recognition for apoptotic and necrotic cells are not specified exclusively by phosphatidylserine exposure. Mol Biol Cell (2001) 1.55

Thymic depletion and peripheral activation of class I major histocompatibility complex-restricted T cells by soluble peptide in T-cell receptor transgenic mice. Proc Natl Acad Sci U S A (1992) 1.52

Peripheral T-cell tolerance induced in naive and primed mice by subcutaneous injection of peptides from the major cat allergen Fel d I. Proc Natl Acad Sci U S A (1993) 1.52

Split tolerance induced by orthotopic liver transplantation in mice. Transplantation (1994) 1.52

Cytotoxic T lymphocytes to an unmutated tumor rejection antigen P1A: normal development but restrained effector function in vivo. J Exp Med (1999) 1.49

Protease inhibitors selectively block T cell receptor-triggered programmed cell death in a murine T cell hybridoma and activated peripheral T cells. J Exp Med (1993) 1.49

Tumor growth enhances cross-presentation leading to limited T cell activation without tolerance. J Exp Med (2002) 1.48

Role of antigen-presenting cells in mediating tolerance and autoimmunity. J Exp Med (2000) 1.46

A single amino acid change in a myelin basic protein peptide confers the capacity to prevent rather than induce experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A (1991) 1.45

Conditions that induce tolerance in mature CD4+ T cells. J Exp Med (1997) 1.45

An exogenous mouse mammary tumor virus with properties of Mls-1a (Mtv-7). J Exp Med (1992) 1.45

Ontogeny of T cell tolerance to peripherally expressed antigens. Proc Natl Acad Sci U S A (1999) 1.43

Interferon-gamma-producing T cells in giant cell vasculitis represent a minority of tissue-infiltrating cells and are located distant from the site of pathology. Am J Pathol (1996) 1.43

The anatomy of T-cell activation and tolerance. Proc Natl Acad Sci U S A (1996) 1.42

The majority of cells infected with the defective murine AIDS virus belong to the B-cell lineage. J Virol (1991) 1.41

Enhanced and accelerated lymphoproliferation in Fas-null mice. Proc Natl Acad Sci U S A (1996) 1.40

Peripheral selection of T cell repertoires: the role of continuous thymus output. J Exp Med (1997) 1.39

Anti-4-1BB monoclonal antibodies abrogate T cell-dependent humoral immune responses in vivo through the induction of helper T cell anergy. J Exp Med (1999) 1.37

Dominant clonotypes in the repertoire of peripheral CD4+ T cells in rheumatoid arthritis. J Clin Invest (1994) 1.37

Constitutive activation of the Fas ligand gene in mouse lymphoproliferative disorders. EMBO J (1995) 1.33

A role for Fas in negative selection of thymocytes in vivo. J Exp Med (1998) 1.30

Peripheral T cell activation and deletion induced by transfer of lymphocyte subsets expressing endogenous or exogenous mouse mammary tumor virus. J Exp Med (1993) 1.29

Early signaling defects in human T cells anergized by T cell presentation of autoantigen. J Exp Med (1992) 1.29

Anti-SCID mouse reactivity shapes the human CD4+ T cell repertoire in hu-PBL-SCID chimeras. J Exp Med (1994) 1.29

Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo. J Exp Med (1998) 1.28

Impaired apoptosis, extended duration of immune responses, and a lupus-like autoimmune disease in IEX-1-transgenic mice. Proc Natl Acad Sci U S A (2002) 1.27

Regulatory T cells specific for the same framework 3 region of the Vbeta8.2 chain are involved in the control of collagen II-induced arthritis and experimental autoimmune encephalomyelitis. J Exp Med (1997) 1.26

Peripheral T cells undergoing superantigen-induced apoptosis in vivo express B220 and upregulate Fas and Fas ligand. J Exp Med (1996) 1.25

Tick transmission of Borrelia burgdorferi to inbred strains of mice induces an antibody response to P39 but not to outer surface protein A. Infect Immun (1994) 1.25

The mouse mammary tumour virus long terminal repeat encodes a type II transmembrane glycoprotein. EMBO J (1992) 1.25

Memory T cells are anergic to the superantigen staphylococcal enterotoxin B. J Exp Med (1992) 1.25

The effects of chronic infection with a superantigen-producing virus. J Exp Med (1992) 1.24

At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy. J Leukoc Biol (2013) 1.21

Abortive proliferation of rare T cells induced by direct or indirect antigen presentation by rare B cells in vivo. J Exp Med (1998) 1.21

Dynamics of suppressor T cells: in vivo veritas. J Exp Med (2003) 1.20

B cells directly tolerize CD8(+) T cells. J Exp Med (1998) 1.20

CD4 T cells in murine acquired immunodeficiency syndrome: polyclonal progression to anergy. J Exp Med (1992) 1.20

A novel Bcl-x isoform connected to the T cell receptor regulates apoptosis in T cells. Immunity (1997) 1.19

Lymphocytes selected in allogeneic thymic epithelium mediate dominant tolerance toward tissue grafts of the thymic epithelium haplotype. Proc Natl Acad Sci U S A (1995) 1.15

Clonal deletion of specific thymocytes by an immunoglobulin idiotype. EMBO J (1993) 1.15

Transferable anergy: superantigen treatment induces CD4+ T cell tolerance that is reversible and requires CD4-CD8- cells and interferon gamma. J Exp Med (1997) 1.15

Coupling of peripheral tolerance to endogenous interleukin 10 promotes effective modulation of myelin-activated T cells and ameliorates experimental allergic encephalomyelitis. J Exp Med (2000) 1.14

T cell receptor V beta gene bias in rheumatoid arthritis. J Clin Invest (1993) 1.12

Superantigens anergize cytokine production but not cytotoxicity in vivo. Immunology (1994) 1.10

Systemic versus cartilage-specific expression of a type II collagen-specific T-cell epitope determines the level of tolerance and susceptibility to arthritis. Proc Natl Acad Sci U S A (1996) 1.10

Timely immunization subverts the development of peripheral nonresponsiveness and suppresses tumor development in simian virus 40 tumor antigen-transgenic mice. Proc Natl Acad Sci U S A (1994) 1.09

Functional cleavage of the common cytokine receptor gamma chain (gammac) by calpain. Proc Natl Acad Sci U S A (1997) 1.09

Cytotoxic T cell response against the chimeric p210 BCR-ABL protein in patients with chronic myelogenous leukemia. J Clin Invest (1998) 1.08

Differential ability of T cell subsets to undergo activation-induced cell death. Proc Natl Acad Sci U S A (1997) 1.08

Mobilizing the low-avidity T cell repertoire to kill tumors. Semin Cancer Biol (2007) 1.08

Cross-species transplantation tolerance: rat bone marrow-derived cells can contribute to the ligand for negative selection of mouse T cell receptor V beta in chimeras tolerant to xenogeneic antigens (mouse + rat----mouse). J Exp Med (1992) 1.07

Analysis of the T-cell receptor beta-chain variable-region (V beta) repertoire in monozygotic twins discordant for human immunodeficiency virus: evidence for perturbations of specific V beta segments in CD4+ T cells of the virus-positive twins. Proc Natl Acad Sci U S A (1994) 1.07

Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejection. Liver Transpl (2000) 1.07

Both intrathymic and peripheral selection modulate the differential expression of V beta 5 among CD4+ and CD8+ T cells. J Exp Med (1992) 1.06

Mechanism of self-tolerance of gamma/delta T cells in epithelial tissue. J Exp Med (1992) 1.06

A regulatory role for TRAF1 in antigen-induced apoptosis of T cells. J Exp Med (1997) 1.05

Oligoclonal expansion of major histocompatibility complex class I-restricted cytolytic T lymphocytes during a primary immune response in vivo: direct monitoring by flow cytometry and polymerase chain reaction. J Exp Med (1993) 1.05

T-cell responsiveness to an oncogenic peripheral protein and spontaneous autoimmunity in transgenic mice. Proc Natl Acad Sci U S A (1992) 1.05

Induction of apoptosis and T helper 2 (Th2) responses correlates with peptide affinity for the major histocompatibility complex in self-reactive T cell receptor transgenic mice. J Exp Med (1997) 1.04

Revenge of the microbes. Superantigens of the T and B cell lineage. Am J Pathol (1994) 1.04

Genetically transferred central and peripheral immune tolerance via retroviral-mediated expression of immunogenic epitopes in hematopoietic progenitors or peripheral B lymphocytes. Mol Med (1997) 1.04

Mouse T lymphocytes that express a gamma delta T-cell antigen receptor contribute to resistance to Salmonella infection in vivo. Infect Immun (1994) 1.04

Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity (1998) 9.02

Turnover of naive- and memory-phenotype T cells. J Exp Med (1994) 8.07

A receptor for antibody on B lymphocytes. I. Method of detection and functional significance. J Exp Med (1972) 7.47

Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science (1996) 7.00

IL-7 is critical for homeostatic proliferation and survival of naive T cells. Proc Natl Acad Sci U S A (2001) 6.91

T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature (1994) 6.20

A monoclonal antibody discriminating between subsets of T and B cells. J Immunol (1981) 6.15

The peptide ligands mediating positive selection in the thymus control T cell survival and homeostatic proliferation in the periphery. Immunity (1999) 6.10

Utilization of bacteriophage T7 late promoters in recombinant plasmids during infection. J Mol Biol (1981) 5.66

Socioeconomic status and breast cancer incidence in California for different race/ethnic groups. Cancer Causes Control (2001) 5.38

Reducing the risk of major elective surgery: randomised controlled trial of preoperative optimisation of oxygen delivery. BMJ (1999) 4.98

Voltage oscillations in the barnacle giant muscle fiber. Biophys J (1981) 4.45

Restricted helper function of F1 hybrid T cells positively selected to heterologous erythrocytes in irradiated parental strain mice. II. Evidence for restrictions affecting helper cell induction and T-B collaboration, both mapping to the K-end of the H-2 complex. J Exp Med (1978) 3.67

Circulating T and B lymphocytes of the mouse. I. Migratory properties. Cell Immunol (1973) 3.53

Etomidate for emergency anaesthesia; mad, bad and dangerous to know? Anaesthesia (2005) 3.46

Lethal graft-versus-host disease after bone marrow transplantation across minor histocompatibility barriers in mice. Prevention by removing mature T cells from marrow. J Exp Med (1978) 3.46

Antigen-induced selective recruitment of circulating lymphocytes. Cell Immunol (1971) 3.35

Quantitative features of a sandwich radioimmunolabeling technique for lymphocyte surface receptors. J Exp Med (1972) 3.28

Epidural analgesia: first do no harm. Anaesthesia (2008) 3.27

Cell-to-cell interaction in the immune response. VI. Contribution of thymus-derived cells and antibody-forming cell precursors to immunological memory. J Exp Med (1971) 3.14

The t(7;11)(p15;p15) translocation in acute myeloid leukaemia fuses the genes for nucleoporin NUP98 and class I homeoprotein HOXA9. Nat Genet (1996) 3.05

Interaction between lymphocytes in immune responses. Cell Immunol (1971) 3.03

Collaboration of histoincompatible T and B lymphocytes using cells from tetraparental bone marrow chimeras. J Exp Med (1975) 3.03

T cell priming in vivo: a major role for B cells in presenting antigen to T cells in lymph nodes. J Immunol (1987) 2.93

Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment. J Clin Oncol (2002) 2.86

Reentry of T cells to the adult thymus is restricted to activated T cells. J Exp Med (1991) 2.81

Properties of purified T cell subsets. I. In vitro responses to class I vs. class II H-2 alloantigens. J Exp Med (1985) 2.79

Choice matters: enrollees' views of their health plans. Health Aff (Millwood) (1995) 2.77

Cell-to-cell interaction in the immune response. X. T-cell-dependent suppression in tolerant mice. J Exp Med (1974) 2.77

TCR-Mediated internalization of peptide-MHC complexes acquired by T cells. Science (1999) 2.70

A defect in central tolerance in NOD mice. Nat Immunol (2001) 2.59

Type I interferon-mediated stimulation of T cells by CpG DNA. J Exp Med (1998) 2.58

Correlation of the highest-energy cosmic rays with nearby extragalactic objects. Science (2007) 2.57

Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial. J Clin Oncol (2002) 2.55

Homeostatic T cell proliferation: how far can T cells be activated to self-ligands? J Exp Med (2000) 2.55

Association of immunity and tolerance to host H-2 determinants in irradiated F1 hybrid mice reconstituted with bone marrow cells from one parental strain. J Exp Med (1975) 2.39

Restricted helper function of F1 hybrid T cells positively selected to heterologous erythrocytes in irradiated parental strain mice. I. Failure to collaborate with B cells of the opposite parental strain not associated with active suppression. J Exp Med (1978) 2.34

Tolerance to histocompatibility determinants in tetraparental bone marrow chimeras. J Exp Med (1975) 2.29

T cell stimulation in vivo by lipopolysaccharide (LPS). J Exp Med (1997) 2.29

Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences. J Exp Med (1986) 2.29

Activation of thymus cells by histocompatibility antigens. Nat New Biol (1971) 2.26

Managed care: promise and concerns. Health Aff (Millwood) (1994) 2.24

Arsenic and mercury intoxication due to Indian ethnic remedies. BMJ (1993) 2.24

Autoantibodies detected to expressed K+ channels are implicated in neuromyotonia. Ann Neurol (1997) 2.17

Restricted helper function of F1 leads to parent bone marrow chimeras controlled by K-end of H-2 complex. J Exp Med (1978) 2.17

Long-term outcome in congenitally corrected transposition of the great arteries: a multi-institutional study. J Am Coll Cardiol (2000) 2.14

Identity of cells that imprint H-2-restricted T-cell specificity in the thymus. Nature (1986) 2.11

Thymus-derived cells in mouse thoracic duct lymph. Nat New Biol (1971) 2.07

ICI 182,780 (Faslodex): development of a novel, "pure" antiestrogen. Cancer (2000) 2.05

Salmonella enterica serovar typhi uses type IVB pili to enter human intestinal epithelial cells. Infect Immun (2000) 2.04

Role of H-2 gene products in the function of T helper cells from normal and chimeric mice in vivo. Immunol Rev (1978) 1.95

Circulating T and B lymphocytes of the mouse. II. Lifespan. Cell Immunol (1973) 1.94

A monoclonal antibody to the heavy chain of clathrin. EMBO J (1983) 1.94

Fate of H2-activated T lymphocytes in syngeneic hosts. I. Fate in lymphoid tissues and intestines traced with 3H-thymidine, 125I-deoxyuridine and 51chromium. Cell Immunol (1976) 1.89

T cells can use either T cell receptor or CD28 receptors to absorb and internalize cell surface molecules derived from antigen-presenting cells. J Exp Med (2000) 1.88

Receptor for antibody-antigen complexes used to separate T cells from B cells. Nat New Biol (1972) 1.87

Doublet discrimination in DNA cell-cycle analysis. Cytometry (2001) 1.83

A monoclonal antibody detecting an Ia specificity mapping in the I-A or I-E subregion. Immunogenetics (1981) 1.83

Comparison of the short-term biological effects of 7alpha-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)-nonyl]estra-1,3,5, (10)-triene-3,17beta-diol (Faslodex) versus tamoxifen in postmenopausal women with primary breast cancer. Cancer Res (2001) 1.81

Increased risk of deep-vein thrombosis in patients with multiple myeloma receiving thalidomide and chemotherapy. Blood (2001) 1.80

Surface immunoglobulins on thymus and thymus-derived lymphoid cells. J Exp Med (1971) 1.79

Interaction of thymus lymphocytes with histoincompatible cells. II. Recirculating lymphocytes derived from antigen-activated thymus cells. Cell Immunol (1972) 1.78

Negative selection in the thymus includes semimature T cells. J Exp Med (1997) 1.77

Isolation and chromosomal localization of CRKL, a human crk-like gene. Oncogene (1993) 1.76

The generation of killer cells to trinitrophenyl-modified allogeneic targets by lymphocyte populations negatively selected to strong alloantigens. J Exp Med (1977) 1.75

Abnormal differentiation of thymocytes in mice treated with cyclosporin A. Nature (1988) 1.73

Health insurance: the size and shape of the problem. Inquiry (1995) 1.71

Regulation of the cross-bridge transition from a weakly to strongly bound state in skinned rabbit muscle fibers. Am J Physiol (1995) 1.71

Requirements for peptide-induced T cell receptor downregulation on naive CD8+ T cells. J Exp Med (1997) 1.70

Interaction of thymus lymphocytes with histoincompatible cells. I. Quantitation of the proliferative response of thymus cells. Cell Immunol (1972) 1.68

Rapid and specific detection of Sin Nombre virus antibodies in patients with hantavirus pulmonary syndrome by a strip immunoblot assay suitable for field diagnosis. J Clin Microbiol (1997) 1.65

Stimulation of mature unprimed CD8+ T cells by semiprofessional antigen-presenting cells in vivo. J Exp Med (1992) 1.61

Two subsets of epithelial cells in the thymic medulla. J Exp Med (1992) 1.59

Upregulation of surface markers on dying thymocytes. J Exp Med (1995) 1.59

Characterization of human antibody responses to four corners hantavirus infections among patients with hantavirus pulmonary syndrome. J Virol (1994) 1.59

Effects of blocking helper T cell induction in vivo with anti-Ia antibodies. Possible role of I-A/E hybrid molecules as restriction elements. J Exp Med (1980) 1.59

Effect of recent antigen priming on adoptive immune responses. I. Specific unresponsiveness of cells from lymphoid organs of mice primed with heterologous erythrocytes. J Exp Med (1973) 1.58

Capacity of unprimed CD4+ and CD8+ T cells expressing V beta 11 receptors to respond to I-E alloantigens in vivo. J Exp Med (1989) 1.58

Rapid relief of acute sore throat with AMC/DCBA throat lozenges: randomised controlled trial. Int J Clin Pract (2009) 1.58

Dangers of lubricants used with condoms. Nature (1988) 1.56

Five types of lymphocytes (Ig-theta-, Ig-theta+weak, Ig-theta+strong, Ig+theta- and Ig+theta+) characterized by double immunofluorescence and electrophoretic mobility. Organ distribution in normal and nude mice. Eur J Immunol (1975) 1.54

Strong T cell tolerance in parent----F1 bone marrow chimeras prepared with supralethal irradiation. Evidence for clonal deletion and anergy. J Exp Med (1990) 1.54

CD40 ligand-mediated interactions are involved in the generation of memory CD8(+) cytotoxic T lymphocytes (CTL) but are not required for the maintenance of CTL memory following virus infection. J Virol (1998) 1.53

Anal and dry sex in commercial sex work, and relation to risk for sexually transmitted infections and HIV in Meru, Kenya. Sex Transm Infect (2006) 1.53

Surface markers of T cells causing lethal graft-vs-host disease to class I vs class II H-2 differences. J Immunol (1985) 1.51

Detection of BRAF mutations in the tumour and serum of patients enrolled in the AZD6244 (ARRY-142886) advanced melanoma phase II study. Br J Cancer (2009) 1.50

Lifespan of gamma/delta T cells. J Exp Med (1998) 1.49

T cell function in bone marrow chimeras: absence of host-reactive T cells and cooperation of helper T cells across allogeneic barriers. Transplant Rev (1976) 1.49

Interaction of thymus lymphocytes with histoincompatible cells. 3. Immunological characteristics of recirculating lymphocytes derived from activated thymus cells. Cell Immunol (1972) 1.49

Measurement of the depth of maximum of extensive air showers above 10{18} eV. Phys Rev Lett (2010) 1.48

Induction of neonatal tolerance to Mlsa antigens by CD8+ T cells. Science (1990) 1.47

Cell-to-cell interaction in the immune response. VII. Requirement for differentiation of thymus-derived cells. J Exp Med (1971) 1.46

Exchange transfusion in the treatment of severe theophylline poisoning. Pediatrics (1992) 1.43

ABR, an active BCR-related gene. Nucleic Acids Res (1989) 1.42

DNA as an adjuvant: capacity of insect DNA and synthetic oligodeoxynucleotides to augment T cell responses to specific antigen. J Exp Med (1998) 1.41

Variable capacity of L3T4+ T cells to cause lethal graft-versus-host disease across minor histocompatibility barriers in mice. J Exp Med (1987) 1.41

Consent for practising difficult intubation techniques. Anaesthesia (2005) 1.40

High incidence of chromosome 13 deletion in multiple myeloma detected by multiprobe interphase FISH. Blood (2000) 1.39

Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection. Mucosal Immunol (2012) 1.39

Sudden death in Williams syndrome: report of ten cases. J Pediatr (1996) 1.38